Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAYTU BIOPHARMA, INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

AYTU BIOPHARMA, INC

$2.05Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $16.11M. Net result −$15K. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $16.11M. Running result $16.11M. Revenue: $16.11M.
  • Cost of revenue: −$5.7M. Running result $10.41M.
  • Gross profit: $10.41M. Running result $10.41M.
  • Selling and marketing: −$6.12M. Running result $4.29M.
  • General and administrative: −$4.31M. Running result −$16K.
  • Research and development: $0. Running result −$16K.
  • Amortization of intangible assets: −$761K. Running result −$777K.
  • Restructuring costs: $0. Running result −$777K.
  • Operating income: −$777K. Running result −$777K.
  • Other income: $773K. Running result −$4K.
  • Pre-tax loss: −$4K. Running result −$4K.
  • Income tax expense: −$11K. Running result −$15K.
  • Net loss: −$15K. Running result −$15K.